Longboard Pharmaceuticals, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Longboard Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2020 to Q3 2024.
  • Longboard Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $3.38M, a 294% increase year-over-year.
  • Longboard Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $8.79M, a 195% increase year-over-year.
  • Longboard Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $3.25M, a 22.5% increase from 2022.
  • Longboard Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $2.66M, a 35.1% increase from 2021.
  • Longboard Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $1.97M, a 76.9% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $8.79M $3.38M +$2.52M +294% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $6.27M $2.81M +$1.97M +234% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $4.31M $1.75M +$1.05M +151% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $3.25M $860K +$268K +45.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-12
Q3 2023 $2.99M $856K +$61K +7.67% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $2.93M $841K +$142K +20.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 $2.78M $697K +$126K +22.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $2.66M $592K +$8K +1.37% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-12
Q3 2022 $2.65M $795K +$257K +47.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $2.39M $699K +$187K +36.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $2.21M $571K +$238K +71.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $1.97M $584K -$6.78M -92.1% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-02
Q3 2021 $8.74M $538K +$40K +8.03% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $8.7M $512K -$43K -7.75% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $8.75M $333K +$238K +251% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $8.51M $7.36M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-03
Q3 2020 $498K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $555K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $95K Jan 3, 2020 Mar 31, 2020 10-Q 2021-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.